Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiome and Response to Cardiovascular Drugs
Sony Tuteja, Jane F. Ferguson
Circulation Genomic and Precision Medicine (2019) Vol. 12, Iss. 9
Open Access | Times Cited: 99

Showing 51-75 of 99 citing articles:

Microbial Features Linked to Medication Strategies in Cardiometabolic Disease Management
Jane Shearer, Shrushti Shah, Grace Shen‐Tu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 991-1001
Closed Access | Times Cited: 2
Microbiome Miracles and their Pioneering Advances and Future Frontiers in Cardiovascular Disease
Mishal Safdar, Muneeb Ullah, Shah Hamayun, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 9, pp. 102686-102686
Closed Access | Times Cited: 2
Insights from metagenomics into gut microbiome associated with acute coronary syndrome therapy
Yuee Guan, Shuru Zhao, Jing Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia
Mohamed Gaber, Adam S. Wilson, Amy E. Millen, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Microbiota Signals during the Neonatal Period Forge Life-Long Immune Responses
Bryan V. Phillips-Farfán, Fernando Gómez‐Chávez, Edgar Alejandro Medina-Torres, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8162-8162
Open Access | Times Cited: 15
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
Anna Gaimari, Michele Fusaroli, Emanuel Raschi, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 663-673
Closed Access | Times Cited: 11
High-fat diet impact on intestinal cholesterol conversion by the microbiota and serum cholesterol levels
Alena M. Bubeck, Paul Urbain, Cathrine Horn, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107697-107697
Open Access | Times Cited: 6
Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
Chen Fang, Kun Zuo, Wanjing Zhang, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 9
Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ
Ioannis Paraskevaidis, Αndrew Xanthopoulos, Elias Tsougos, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2574-2574
Open Access | Times Cited: 5
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Martina Belli, Lucy Barone, Susanna Longo, et al.
(2023)
Open Access | Times Cited: 4
Human Gut Microbiome in Heart Failure: Trying to Unmask an Emerging Organ
Ioannis Paraskevaidis, Αndrew Xanthopoulos, Elias Tsougkos, et al.
(2023)
Open Access | Times Cited: 4
Cardiovascular diseases and the heart–gut cross talk
Snehali Majumder, Rohan Makwana, Varun Shetty, et al.
Indian Heart Journal (2023) Vol. 76, Iss. 2, pp. 94-100
Open Access | Times Cited: 4
Effects of statins beyond lipid-lowering agents in ART-treated HIV infection
Vikram Mehraj, Jun Chen, Jean‐Pierre Routy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Unveiling gut microbiota's role: Bidirectional regulation of drug transport for improved safety
Jinyi Wang, Tingting Zhou
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 311-343
Closed Access | Times Cited: 1
The Role of Gut Microbiota Dysbiosis Induced by Circadian Rhythm Disruption in Cardiometabolic Diseases
Qin-yao Li, Chang Liu, Yixin Zhang, et al.
(2024)
Open Access | Times Cited: 1
Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: any place for drug repurposing?
Elisa Avolio, Barbara Bassani, Marzia Campanile, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100033-100033
Open Access | Times Cited: 1
2021 American Thoracic Society BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension
Daphne Moutsoglou
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 205, Iss. 1, pp. 13-16
Open Access | Times Cited: 9
How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper
Eva Neumann, Filippa Schreeck, Jethro Herberg, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 12, pp. 5017-5033
Open Access | Times Cited: 6
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid
Vimal Mehta, Raman Puri, P. Barton Duell, et al.
Journal of the Association of Physicians of India (2022) Vol. 70, Iss. 9, pp. 67-75
Open Access | Times Cited: 6
Host-microbe tryptophan partitioning in cardiovascular diseases
Matteo Antonio Russo, Enrico Garaci, Andrea Frustaci, et al.
Pharmacological Research (2023) Vol. 198, pp. 106994-106994
Open Access | Times Cited: 3
Predictors of gastrointestinal complaints in patients on metformin therapy
Branislava Raičević, Slobodan Јаnkovic
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Interactions between Medications and the Gut Microbiome in Inflammatory Bowel Disease
Julia Eckenberger, James C. Butler, Çharles N. Bernstein, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1963-1963
Open Access | Times Cited: 5
Data-driven microbiota biomarker discovery for personalized drug therapy of cardiovascular disease
Li Shen, Ke Shen, Jinwei Bai, et al.
Pharmacological Research (2020) Vol. 161, pp. 105225-105225
Closed Access | Times Cited: 7
Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy
Lamiaa A. Ahmed, Khaled F. Al-Massri
Current Molecular Pharmacology (2022) Vol. 16, Iss. 1, pp. 43-59
Closed Access | Times Cited: 4
Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats
Rong Zhou, Haijun Yang, Peng Zhu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2085-2085
Open Access | Times Cited: 2

Scroll to top